|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00670371 |
The objective is to find determinants for the subjective and objective burden of informal caregivers to patients who are requiring continued antipsychotic treatment for functional psychoses among factors related to the patient, the health care and support provision system and the informal caregiver him/her-self.
Condition |
Functional Psychoses Informal Caregivers |
MedlinePlus related topics: | Caregivers Psychotic Disorders |
Study Type: | Observational |
Study Design: | Other, Cross-Sectional |
Official Title: | Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study |
Estimated Enrollment: | 100 |
Study Start Date: | March 2008 |
Estimated Study Completion Date: | May 2009 |
Groups/Cohorts |
1
Patients having the following diagnoses are eligible for inclusion into the study: schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, delusional disorder, affective psychosis with mood incongruent delusions, psychotic disorder not otherwise specified or patients being actively psychotic.
|
2
Closest relative(s) /informal caregiver(s)
|
The study also comprises a descriptive part with the aim:
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Psychiatric patients and informal caregivers. Selected from outpatient wards
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZenec Sweden Clinical Study Information | +46 8 553 260 00 |
Sweden | |||||
Research Site | Recruiting | ||||
LIDINGO, Sweden | |||||
Research Site | Recruiting | ||||
FALKOPING, Sweden | |||||
Research Site | Recruiting | ||||
LJUNGBY, Sweden | |||||
Research Site | Recruiting | ||||
Solna, Sweden | |||||
Research Site | Recruiting | ||||
MALMO, Sweden | |||||
Research Site | Recruiting | ||||
Göteborg, Sweden | |||||
Research Site | Recruiting | ||||
STOCKHOLM, Sweden |
AstraZeneca |
Study Director: | Birgit Ekholm | AstraZeneca, MC, Sweden |
Principal Investigator: | Lena Flyckt | Danderyds Hospital, Stockholm |
Responsible Party: | AstraZeneca Pharmaceuticals ( Birgit Ekholm, MD, Medical Director Neuroscience ) |
Study ID Numbers: | NIS-NSE-DUM-2007/1 |
First Received: | April 29, 2008 |
Last Updated: | October 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00670371 |
Health Authority: | Sweden: Regional Ethical Review Board |
|
|